Indications for Palliative Reduction Surgery for Hepatocellular Carcinoma with Multiple Intrahepatic Metastases

Hiroshima Journal of Medical Sciences

Volumn 47, Issue 3, 1998, Pages 115-120

  Asahara, Toshimasa ^a   Itamoto, Toshiyuki ^a   Katayama, Koji ^a   Nakahara, Hideki ^a   Okamoto, Yuzo ^a   Hino, Hiroshi ^a   Ono, Eiji ^a   Dohi, Kiyohiko ^a   Nakanishi, Toshio ^a   Kitamoto, Mikiya ^a   Moriwaki, Katsufumi ^a   Yuge, Osafumi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Intrahepatic matastasis

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PROGNOSIS; SURVIVAL RATE;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; SURVIVAL RATE;

EID: 0032163374     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Edmondson, H.A. and Steiner, P.E. 1954. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503.
2. Groupe d'etude et de traitement du carcinome hepatocellulaire. 1995. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N. Engl. J. Med. 332: 1256-1261.
3. Higuehi, T., Kikuchi, M. and Okazaki, M. 1994. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 73: 2259-2267.
4. Hsu, H.C., Chiou, T.Z., Chen, J.Y., Lee, C.S., Lee, P.H. and Peng, S.Y. 1990. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology 13: 923-928.
5. International Union Against Cancer. 1997. Liver (ICD-O C22), p.74-77, In L.H. Sobin and Ch. Wittekind, (eds.), TNM Classification of Malignant Tumors 5th ed. Springer, Berlin.
6. Kanematsu, T., Inokuchi, K., Sugimachi, K., Furuta, T., Sonoda, T., Tanoura, S. and Hasuo, K. 1984. Selective effects of lipiodolized antitumor agents. J. Surg. Oncol. 25: 218-226.
7. Liver cancer study group of Japan. 1992. The general rules for the clinical and pathological study of primary liver cancer, 3rd edn (in Japanese) Kanehara Shuppan, Tokyo.
8. Makuuchi, M., Hasegawa, H. and Yamazaki, S. 1985. Ultrasonically guided subsegmentectomy. Surg. Gynecol. Obstet. 161: 346-350.
9. Mitsunobu, M., Toyosaka, A., Oriyama, T., Okamoto, E. and Nakao, N. 1996. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin. Exp. Metastasis 14: 520-529.
10. Noguchi, T., Imai, T. and Mizumoto, R. 1990. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepato-gastroenterol. 37: 165-171.
11. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M. and Hirohashi, S. 1992. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res. 52: 3674-3678.
12. Okuda, K. 1986. Early recognition of hepatocellular carcinoma. Hepatology 4: 729-738.
13. Ozawa, K., Takayasu, T., Kumada, K., Yamaoka, Y., Tanaka, K., Kobayashi, N., Inamoto, T., Shimahara, Y., Mori, K., Honda, K. and Asonuma, K. 1991. Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period. Am. J. Surg. 161: 677-682.
14. Pichlmayr, R., Weimann, A., Oldhafer, K.J., Schlitt, H.J., Klempnauer, J., Bornscheuer, A., Chavan, A., Schmoll, E., Lang, H., Tusch, G. and Ringe, B. 1995. Role of liver transplantation in the treatment of unresectable liver cancer. World. J. Surg. 19: 807-813.
15. Pugh, R.N.H., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C. and Williams, R. 1973. Transection of oesophagus for bleeding varices. Br. J. Surg. 60: 646-649.
16. Tobe, T. and Arii, S. 1992. Improving survival after resection of hepatocellular carcinoma: Characteristics and current status of surgical treatment of primary liver cancer in Japan, p.215-220. In T.Tobe, H.Kameda, M.Okudaira, et al. (eds.), Primary liver cancer in Japan. Springer-Verlag, Tokyo.
17. Urata, K., Matsumata, T., Kamakura, T., Hasuo, K. and Sugimachi, K. 1994. Lipiodolization for unresectable hepatocellular carcinoma: An analysis of 205 patients using univariate and multivariate analysis. J. Surg. Oncol. 56: 54-58.
18. Yamada, R., Kishi, K., Terada, M., Sonomura, T. and Sato, M. 1992. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.p.259-271. In T. Tobe, H. Kameda, M.Okudaira, et al. (eds.), Primary liver cancer in Japan. Springer-Verlag, Tokyo.
19. Yamamoto, K., Takenaka, K., Kawahara, N., Shimada, M., Shirabe, K., Itasaka, H., Nishizaki, T., Yanaga, K. and Sugimachi, K. 1997. Indications for palliative reduction surgery in advanced hepatocellular carcinoma. The use of a remnant tumor index. Arch. Surg. 132: 120-123.
20. Yamamoto, M., Iizuka, H., Matsuda, M., Nagahori, K., Miura, K. and Itakura, J. 1993. The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma. Surg. Today 13: 675-681.
21. Yamanaka, N., Tanaka, T., Oriyama, T., Furukawa, K., Tanaka, W. and Okamoto, E. 1996. Microwave coagulonecrotic therapy for hepatocellular carcinoma. World J. Surg. 20: 1076-1081.